Our Story

After earning his PhD at UCSF, Dr. Regan was recruited by Lawrence Livermore National Laboratory, where he developed advanced bio-warfare surveillance and respiratory pathogen detection systems for the U.S. Department of Homeland Security’s BioWatch program. Drawing from his experience in both government and the diagnostics industry, he founded MantaBio to bring cutting-edge genetic testing to underserved markets.

In 2025, MantaBio was born with a clear mission: to revolutionize microbial testing in biologics manufacturing. Despite massive advancements in medicine, biopharma manufacturers still rely on culture-based testing—a decades-old method that takes days or even weeks for results.

Our vision is clear: to retire culture-based testing and set a new gold standard. Our next-generation genetic testing system will deliver results in just two hours, be effortless to use, and provide unmatched sensitivity, specificity, and breadth of coverage—empowering biopharma companies to operate with greater speed, safety, and confidence